ProShare Advisors’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-611
Closed -$15K 2352
2021
Q3
$15K Buy
+611
New +$15K ﹤0.01% 2000
2021
Q2
Sell
-933
Closed -$115K 2409
2021
Q1
$115K Buy
933
+126
+16% +$15.5K ﹤0.01% 2146
2020
Q4
$92K Buy
807
+560
+227% +$63.8K ﹤0.01% 2003
2020
Q3
$30K Buy
247
+46
+23% +$5.59K ﹤0.01% 1616
2020
Q2
$25K Buy
+201
New +$25K ﹤0.01% 1655